Indenopyridine Derivatives
l-CDB-4022, RTI-4587-073(l)
- User: Male
- Hormonal: Non-Hormonal
-
Delivery type:
- Not Yet Determined
-
Intended Duration:
- Not Yet Determined
- Development Stage: Discovery & Early Development
- Developer(s)/researcher(s): BIOQUAL, National University of La Plata, Argentina
Details
- API: l-CDB-4022
- Target: Not Yet Determined
-
Mechanism of Action:
- Not Yet Determined
- Inactive Materials: Not Yet Determined
- Regimen: Not Yet Determined
- MPT: Not Potential MPT
- Promising Attributes: Human-focused research has stalled, likely due to minimal potential for reversibility. However, the indenopyridine does show reliable in vivo and in vitro (rat studies) antispermatogenic activity.
Product Status
While human use does not appear to have been found non-viable, recent evaluation of idenopyridine has focused exclusively on non-human applications.
History
While near-exclusively evaluated for veterinary applications, 2008 research using a non-proprietary version of the same indenopyridine (I-CDB-4022) suggested its potential use in human males.